Some people with type 2 diabetes might have trouble hitting their health targets, despite lifestyle changes and taking GLP-1 medications. GLP-1 medications like Ozempic and Mounjaro can lead to weight ...

Microdosing is the off-label use of GLP-1 receptor agonists at doses lower than those approved for the treatment of diabetes or obesity. There are numerous reasons people may explore microdosing, ...

Liver disease can progress for years without symptoms, so it’s essential to stay up-to-date on your blood tests and get liver scans when appropriate. Liver disease affects many people with diabetes, ...

Editor's note: Some of the terms around this topic may be new or unfamiliar. Jump to the end of the article for a few helpful definitions. Claire Hinkle shares her experience coming out as transgender ...

From navigating the healthcare system to figuring out how to manage diabetes medications while on gender-affirming hormone therapy, being a transgender person with diabetes comes with additional ...

This lettuce-wrapped smash-and-fry burger recipe is diabetes-friendly and has only 3 grams of carbs per serving. As anyone who is avoiding carbs or gluten already knows, a burger wrapped in a single ...

GLP-1-based medications have revolutionized blood sugar and weight management, but they aren’t effective for everyone. Eli Lilly, which makes the GLP-1/GIP drug Mounjaro (tirzepatide), is currently ...

What is a prior authorization? Read on to learn more about why diabetes supplies or medications might require a prior authorization and how to go through the process It can be frustrating to learn ...

Exercise at a steady pace for short periods can help reduce blood sugar. Avoid intense or vigorous exercise with hyperglycemia, as it can make blood sugar spike higher. You can make simple ...

The launch of generic Victoza comes amid shortages for many different GLP-1 and incretin medications for type 2 diabetes and weight loss. Generic Victoza will cost $469.60 for a 2-pack and $704.40 for ...

The first successful transplants of insulin-producing cells in people with type 1 diabetes occurred about 25 years ago. In recent years, advances once considered hypothetical, such as creating and ...